Page last updated: 2024-11-07

prednisone and Myofibromatosis

prednisone has been researched along with Myofibromatosis in 1 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Myofibromatosis: A condition characterized by multiple formations of myofibromas (LEIOMYOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diop, B1
Konate, I1
Ka, S1
Sall, I1
Fall, D1
Dieng, M1
Wone, Y1

Other Studies

1 other study available for prednisone and Myofibromatosis

ArticleYear
Mesenteric myofibroblastic tumor: NSAID therapy after incomplete resection.
    Journal of visceral surgery, 2011, Volume: 148, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Humans; Indomethacin; Male; Mesent

2011